Catalyst Capital Advisors LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Catalyst Capital Advisors LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$2,802,984
-20.8%
27,518
-21.6%
0.08%
-24.3%
Q2 2023$3,540,831
-2.8%
35,089
-11.4%
0.10%
-7.2%
Q1 2023$3,642,188
-1.1%
39,589
-2.4%
0.11%
-7.5%
Q4 2022$3,681,418
+13.8%
40,580
-4.7%
0.12%
-1.6%
Q3 2022$3,236,000
-10.1%
42,5800.0%0.12%
-18.7%
Q2 2022$3,599,000
-3.7%
42,5800.0%0.15%
-6.8%
Q1 2022$3,736,000
+6.6%
42,580
+6.2%
0.16%
-0.6%
Q4 2021$3,506,000
+15.6%
40,080
+8.1%
0.16%
+6.6%
Q3 2021$3,032,000
-13.0%
37,080
-2.9%
0.15%
-11.6%
Q2 2021$3,484,000
+16.1%
38,180
+8.8%
0.17%
+3.6%
Q1 2021$3,000,000
-8.9%
35,092
+0.6%
0.17%
-9.8%
Q4 2020$3,293,000
+8.6%
34,8700.0%0.18%
+7.6%
Q3 2020$3,032,000
-0.5%
34,8700.0%0.17%
+8.9%
Q2 2020$3,046,000
+5.9%
34,8700.0%0.16%
+9.0%
Q1 2020$2,875,000
-8.2%
34,870
+5.4%
0.14%
+42.6%
Q4 2019$3,132,000
+9.0%
33,0750.0%0.10%
+4.1%
Q3 2019$2,874,000
-4.8%
33,0750.0%0.10%
-3.0%
Q2 2019$3,020,000
+16.0%
33,075
+22.2%
0.10%
+9.9%
Q1 2019$2,603,000
+21.0%
27,075
+8.0%
0.09%
+13.8%
Q4 2018$2,152,000
-0.4%
25,0750.0%0.08%
+12.7%
Q3 2018$2,161,000
+14.1%
25,0750.0%0.07%
+6.0%
Q2 2018$1,894,000
-6.6%
25,0750.0%0.07%
-8.2%
Q1 2018$2,027,000
-3.8%
25,0750.0%0.07%
-6.4%
Q4 2017$2,106,000
-2.2%
25,0750.0%0.08%
-17.0%
Q3 2017$2,153,000
+10.3%
25,075
+7.3%
0.09%
+13.3%
Q2 2017$1,952,000
+12.4%
23,3750.0%0.08%
-3.5%
Q1 2017$1,736,000
+1.9%
23,3750.0%0.09%
-21.1%
Q4 2016$1,703,000
-2.3%
23,375
+5.9%
0.11%
-43.2%
Q3 2016$1,743,000
+3.2%
22,075
+7.8%
0.19%
-38.5%
Q2 2016$1,689,000
+29.7%
20,475
+13.9%
0.31%
+42.5%
Q1 2016$1,302,000
-6.7%
17,975
+10.8%
0.22%
+8.4%
Q4 2015$1,396,000
-6.4%
16,2250.0%0.20%
+1.0%
Q3 2015$1,491,000
-6.6%
16,2250.0%0.20%
+7.5%
Q2 2015$1,596,000
-0.2%
16,2250.0%0.19%
+1.1%
Q1 2015$1,600,000
+6.4%
16,2250.0%0.18%
+4.0%
Q4 2014$1,504,000
-1.5%
16,2250.0%0.18%
-10.2%
Q3 2014$1,527,000
+47.5%
16,225
+42.0%
0.20%
+16.6%
Q2 2014$1,035,000
+6.5%
11,4250.0%0.17%
-23.2%
Q1 2014$972,000
+10.2%
11,425
+4.1%
0.22%
-22.5%
Q4 2013$882,000
+4.8%
10,9750.0%0.28%
-38.4%
Q3 2013$842,000
+67.7%
10,975
+54.6%
0.46%
+18.5%
Q2 2013$502,0007,1000.39%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders